Literature DB >> 1390681

Role of quinone-iron(III) interaction in NADPH-dependent enzymatic generation of hydroxyl radicals.

S I Dikalov1, G V Rumyantseva, A V Piskunov, L M Weiner.   

Abstract

To study the effect of chelation of iron ions by quinones on the generation of OH radicals in biological redox systems, we have synthesized quinones that can form complexes with Fe(III) ions: 2-phenyl-4-(butylamino)naphtho[2,3-h]quinoline-7,12-dione (Qbc) and 2-phenyl-4-(octylamino)naphtho[2,3-h]quinoline-7,12-dione (Qoc). A quinone with a similar structure without chelating group was synthesized as a control sample: 2-phenyl-5-nitronaphtho[2,3-g]indole-6,11-dione (Qn). Using optical spectroscopy, we determined the stability constant of Qbc with Fe(III) [Ks = (7 +/- 1) x 10(18) M-3] and the stoichiometry of the complex Fe(Qbc)3 in chloroform solutions. One-electron reduction potentials of Qbc, Qn, and adriamycin in dimethyl sulfoxide were measured by cyclic voltammetry. In the presence of Fe(III) the one-electron reduction potentials shifted toward positive values by 0.16 and 0.1 V for Qbc and adriamycin, respectively. Using the spin trap 5,5'-dimethyl-1-pyroline N-oxide (DMPO) and EPR, it was found that Qbc in the Fe(III) complex stimulated the formation of OH radicals in the enzymatic system consisting of NADPH and NADPH-cytochrome P-450 reductase more efficiently than adriamycin and quinone Qn. This is indicated by the absence of a lag period in the spin adduct appearance for Qbc and by a significantly higher rate of the spin adduct production, as well as by a larger absolute concentration of the spin adduct obtained for Qbc in comparison with Qn in the presence of Fe(III).(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1390681     DOI: 10.1021/bi00152a034

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  7 in total

1.  Formation of adriamycin--DNA adducts in vitro.

Authors:  C Cullinane; S M Cutts; A van Rosmalen; D R Phillips
Journal:  Nucleic Acids Res       Date:  1994-06-25       Impact factor: 16.971

2.  Aerobic inactivation of fumarate reductase from Escherichia coli by mutation of the [3Fe-4S]-quinone binding domain.

Authors:  G Cecchini; H Sices; I Schröder; R P Gunsalus
Journal:  J Bacteriol       Date:  1995-08       Impact factor: 3.490

Review 3.  Natural product inhibitors of Hsp90: potential leads for drug discovery.

Authors:  M W Amolins; B S J Blagg
Journal:  Mini Rev Med Chem       Date:  2009-02       Impact factor: 3.862

4.  HSP90 inhibitor 17-DMAG exerts anticancer effects against gastric cancer cells principally by altering oxidant-antioxidant balance.

Authors:  Jeong Goo Kim; Sang Chul Lee; Ok-Hee Kim; Kee-Hwan Kim; Kyo Young Song; Sang Kuon Lee; Byung Jo Choi; Wonjun Jeong; Say-June Kim
Journal:  Oncotarget       Date:  2017-04-10

5.  The Interplay of Ascorbic Acid with Quinones-Chelators-Influence on Lipid Peroxidation: Insight into Anticancer Activity.

Authors:  Olga Yu Selyutina; Polina A Kononova; Vladimir E Koshman; Lidiya G Fedenok; Nikolay E Polyakov
Journal:  Antioxidants (Basel)       Date:  2022-02-13

Review 6.  Biomedical Applications for Gold Nanoclusters: Recent Developments and Future Perspectives.

Authors:  Navdeep Kaur; Robby Nur Aditya; Arshdeep Singh; Tsung-Rong Kuo
Journal:  Nanoscale Res Lett       Date:  2018-09-26       Impact factor: 4.703

Review 7.  Combination of Anti-Cancer Drugs with Molecular Chaperone Inhibitors.

Authors:  Maxim Shevtsov; Gabriele Multhoff; Elena Mikhaylova; Atsushi Shibata; Irina Guzhova; Boris Margulis
Journal:  Int J Mol Sci       Date:  2019-10-24       Impact factor: 5.923

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.